Cartesian Therapeutics (RNAC) Interest & Investment Income (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Interest & Investment Income of $1.0 million for Q1 2026, down 49.08% year-over-year from $2.0 million in Q1 2025, and down 19.09% quarter-over-quarter from $1.3 million in Q4 2025.
Cartesian Therapeutics (RNAC) Interest & Investment Income (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Interest & Investment Income for 11 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 49.08% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $5.6 million (down 32.14% YoY), while the FY2025 annual figure was $6.6 million, down 10.93% from the prior year.
- Interest & Investment Income declined to $1.0 million in Q1 2026 per RNAC's latest filing, from $1.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.0 million in Q4 2023 and bottomed at $11000.0 in Q1 2023.
- Historically, Interest & Investment Income has averaged $1.4 million across 5 years, with a median of $1.2 million in 2024.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 25968.42% — and 2024, when it slumped 50.45%.
- Cartesian Therapeutics' Interest & Investment Income stood at $19000.0 in 2022, then surged by 25968.42% to $5.0 million in 2023, then plunged by 50.45% to $2.5 million in 2024, then plunged by 48.33% to $1.3 million in 2025, then slipped by 19.09% to $1.0 million in 2026.
- Business Quant data shows RNAC's Interest & Investment Income at $1.0 million in Q1 2026, $1.3 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 2.02 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 4.95 Mn |
| Jun 30, 2023 | 1.39 Mn |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 19,000.00 |
| Sep 30, 2022 | 710,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 1,000.00 |